Pharma Capital
EPIC: IXI
Market: AIM
52-week High/Low: 44.00p / 22.00p
Sector: Pharma & Biotech
Market Cap: 7.17M
Phone: +44 (0)20 7691 1122
Address: 2 Royal College Street, London NW1 0NH.
Website: www.ixico.com

Established in 2004, our innovative technologies help those involved in researching and treating serious diseases to make rapid decisions and improve patient outcomes. While our clinical focus is predominantly dementia, we also support clinical studies for other disease areas in the field of neuro-degeneration and beyond.

IXICO Plc

www.ixico.com

Interactive graph

col 3
col 4
col 5
col 6

IXICO Plc Timeline

View All

Market Reports Including IXI

VIEW ALL

Executive video interviews

VIEW ALL VIDEOS

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.